Log In
Print this Print this

Botulinum Toxin Vaccine

  Manage Alerts
Collapse Summary General Information
Company Molecular Targeting Technologies Inc.
DescriptionBoNT HC50 expressed on the virion surface of rabies virus
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsPrevent botulinum toxin
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today